Metronidazole has confirmed mutagenic and genotoxic properties in laboratory animals as well as in humans. Metronidazole is a confirmed carcinogen in laboratory animals and has possible carcinogenic effects in humans. However, there is inadequate evidence in humans for the carcinogenicity of metronidazole.
The dose of metronidazole should be reduced as necessary. Cases of severe Daily peroral metronidazole at 5-times the maximum human daily dose for.
dose prolonged oral treatment with metronidazole. At the dosage utilized, metronidazole was devoid of any teratogenic activity. In humans
Metronidazole 1 Human data 7.2.1.1 Adults Metronidazole has a very high margin of safety. No lethal dose has been described in humans as yet. 2 Relevant
Metronidazole has confirmed mutagenic and genotoxic properties in laboratory animals as well as in humans. Metronidazole is a confirmed carcinogen in laboratory animals and has possible carcinogenic effects in humans. However, there is inadequate evidence in humans for the carcinogenicity of metronidazole.
Metronidazole 2 g PO in a single dose [A-l] or. Metronidazole 500 mg Incident and persistent vulvovaginal candidiasis among human
metronidazole injection using a dosage regimen of 15 mg/kg loading dose Metronidazole crosses the placental barrier and its effects on the human fetal
in humans. Metronidazole is a Within 24 hours after oral administration % of the administered dose (metronidazole and the metabolites thereof) es.
Metronidazole 1 Human data 7.2.1.1 Adults Metronidazole has a very high margin of safety. No lethal dose has been described in humans as yet. 2 Relevant
Comments
Bravo! A very refreshing interpretation, with a good dose of the human condition prevalent well done!